ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Syros Pharmaceuticals Inc

Syros Pharmaceuticals Inc (SYRS)

0,105
0,00
(0,00%)
Beim Schlusskurs: 22 April 10:00PM
0,105
0,00
( 0,00% )
Nach Börsenschluss: -

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,105
Gebot
0,10
Fragen
0,1099
Volumen
-
0,00 Tagesbereich 0,00
0,065 52-Wochen-Bereich 6,9275
Marktkapitalisierung
Handelsende
0,105
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
23.566.103
Ausgegebene Aktien
26.832.457
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,95
Gewinn pro Aktie (EPS)
-6,13
Erlöse
9,94M
Nettogewinn
-164,57M

Über Syros Pharmaceuticals Inc

Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and ... Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Syros Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SYRS. The last closing price for Syros Pharmaceuticals was US$0,11. Over the last year, Syros Pharmaceuticals shares have traded in a share price range of US$ 0,065 to US$ 6,9275.

Syros Pharmaceuticals currently has 26.832.457 shares in issue. The market capitalisation of Syros Pharmaceuticals is US$2,82 million. Syros Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.95.

SYRS Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.1050.1050.10500CS
4000.1050.1050.10500CS
12-0.0952-47.55244755240.20020.29690.065235661030.1260523CS
26-2.125-95.29147982062.233.40.065160038510.19232865CS
52-4.465-97.70240700224.576.92750.06580206270.23225226CS
156-0.925-89.80582524271.038.170.06529034380.39902093CS
260-8.475-98.77622377628.5815.64990.06519890581.21739869CS

SYRS - Frequently Asked Questions (FAQ)

What is the current Syros Pharmaceuticals share price?
The current share price of Syros Pharmaceuticals is US$ 0,105
How many Syros Pharmaceuticals shares are in issue?
Syros Pharmaceuticals has 26.832.457 shares in issue
What is the market cap of Syros Pharmaceuticals?
The market capitalisation of Syros Pharmaceuticals is USD 2,82M
What is the 1 year trading range for Syros Pharmaceuticals share price?
Syros Pharmaceuticals has traded in the range of US$ 0,065 to US$ 6,9275 during the past year
What is the PE ratio of Syros Pharmaceuticals?
The price to earnings ratio of Syros Pharmaceuticals is -1,95
What is the cash to sales ratio of Syros Pharmaceuticals?
The cash to sales ratio of Syros Pharmaceuticals is 32,3
What is the reporting currency for Syros Pharmaceuticals?
Syros Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Syros Pharmaceuticals?
The latest annual turnover of Syros Pharmaceuticals is USD 9,94M
What is the latest annual profit for Syros Pharmaceuticals?
The latest annual profit of Syros Pharmaceuticals is USD -164,57M
What is the registered address of Syros Pharmaceuticals?
The registered address for Syros Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Syros Pharmaceuticals website address?
The website address for Syros Pharmaceuticals is www.syros.com
Which industry sector does Syros Pharmaceuticals operate in?
Syros Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SNOASonoma Pharmaceuticals Inc
US$ 3,91
(67,81%)
3,7M
NDRAENDRA Life Sciences Inc
US$ 5,01
(62,38%)
212,28k
PEGAPegasystems Inc
US$ 83,51
(21,45%)
53,11k
MINDMIND Technology Inc
US$ 6,2511
(14,91%)
64,41k
CVGICommercial Vehicle Group Inc
US$ 1,05
(10,53%)
4,79k
MRINMarin Software Incorporated
US$ 0,6461
(-21,75%)
476,54k
SXTCChina SXT Pharmaceuticals Inc
US$ 1,75
(-15,87%)
458,61k
SISIShineco Inc
US$ 0,688
(-12,97%)
63,22k
OBLGOblong Inc
US$ 3,13
(-11,58%)
341,9k
GELSGelteq Ltd
US$ 2,61
(-9,38%)
333,73k
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7,50
(1,49%)
12,68M
TSLATesla Inc
US$ 239,7899
(0,76%)
6,56M
DMNDamon Inc
US$ 0,0038
(-2,56%)
5,98M
SNOASonoma Pharmaceuticals Inc
US$ 3,91
(67,81%)
3,7M
PTPIPetros Pharmaceuticals Inc
US$ 0,0569
(5,76%)
2,92M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock